Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patients @KHOU
Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patients @KHOU
Uploaded August 2026 | Updated September 2026, 3 weeks ago
The popular type two diabetes drug now has FDA approval for lowering the risk of heart attack, stroke, and cardiovascular death in diabetes patients.
Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patientsNick Caserio calls NFL players returning to college ‘ridiculous’2025 Houston snow: Bulldog puzzled by the cold white stuffCoogs play their first game Saturday at TDECU Stadium vs. Oregon StateWeve got to go out there and play well, says Espada of homestandLive: Edouard weakens into a tropical depression as it continues moving inlandWatch live: Texans players speak following Wednesdays practiceWhich Texans roster cut has the most reason to be disappointed? | Sports ExtraWhen AI Hacks Another AITropical Storm Edouard: Officials explain why Lake Houston water levels were loweredDust storm blankets town in northern ColoradoTexas Killing Fields Trial testimony to begin Tuesday, weather permitting
KHOU 11 |

Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patients

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER